NMD Pharma Raises €35 Million in a new Financing
Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million New Financing | Business Wire
NMD Pharma - PIR International
Thomas Holm Pedersen - Roller i dansk erhvervsliv
NMD Pharma (@NMDPharma) / Twitter
NMD Pharma begins first clinical trial: "Our entire team can be enormously proud" — MedWatch
Management team — NMD Pharma
Thomas Holm Pedersen (@NMDpharmaThomas) / Twitter
Thomas Holm Pedersen – CEO – NMD Pharma A/S | LinkedIn
Thomas Pedersen email address & phone number | NMD Pharma A/S CEO contact information - RocketReach
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Stor pariserfond investerer i dansk biotekselskab: Scorer over 250 mio. kr. for anden gang
NMD Pharma Raises €35 Million in a new Financing — NMD Pharma
Thomas Holm Pedersen (@NMDpharmaThomas) / Twitter
Following a compound from start to finish - Nordic Life Science – the leading Nordic life science news service
NMD Pharma (@NMDPharma) / Twitter
Following a compound from start to finish - Nordic Life Science – the leading Nordic life science news service
NMD Pharma receives Orphan Drug Designation from FDA for NMD670 for the Treatment of Myasthenia Gravis | BioSpace
NMD Pharma A/S | LinkedIn
NMD Pharma cleared for spinal muscular atrophy trial
NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn
Thomas Holm Pedersen (@NMDpharmaThomas) / Twitter
Management team — NMD Pharma
NMD Pharma will be at LSX Nordic Congress — NMD Pharma
NMD Pharma expands its US presence — NMD Pharma
Thomas Holm Pedersen on LinkedIn: Happy to share that NMD was awarded the Startup of the Year 2022 at Aarhus…
NMD PHARMA APS innovation strategy - GoodIP
